Ryan P. Roop, MD | Authors

BLOOMINGTON DRUG

509 W 98TH ST

509 W 98TH ST

Articles

PARP Inhibitors and Their Evolving Role in Breast Cancer

October 12, 2011

Poly(adenosine diphosphate [ADP]–ribose) polymerase (PARP) inhibitors are designed to exploit the “synthetic lethality” concept for cancer therapy.